Editorials
The re-birth of hepatic arterial infusion for colorectal liver metastases
Journal of Gastrointestinal Oncology
2013;
4
(2)
:118-120
.
(19 June 2013)
The role of Endoscopic Ultrasound (EUS) in the management of patients with pancreatic cancer: now bigger than ever
Journal of Gastrointestinal Oncology
2013;
4
(2)
:121-122
.
(19 June 2013)
Original Articles
A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer
Journal of Gastrointestinal Oncology
2013;
4
(2)
:123-130
.
(19 June 2013)
Hepatosplenic alpha/beta T-cell lymphoma masquerading as cirrhosis
Journal of Gastrointestinal Oncology
2013;
4
(2)
:131-136
.
(19 June 2013)
Neoadjuvant chemoradiotherapy for esophageal/ gastroesophageal carcinoma
Journal of Gastrointestinal Oncology
2013;
4
(2)
:137-143
.
(19 June 2013)
Clinical applications of gene expression in colorectal cancer
Journal of Gastrointestinal Oncology
2013;
4
(2)
:144-157
.
(19 June 2013)
Differential lymph node retrieval in rectal cancer: associated factors and effect on survival
Journal of Gastrointestinal Oncology
2013;
4
(2)
:158-163
.
(19 June 2013)
Recent advances and significance of intra-arterial infusion chemotherapy in non-resectable colorectal liver metastasis
Journal of Gastrointestinal Oncology
2013;
4
(2)
:164-172
.
(19 June 2013)
Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy
Journal of Gastrointestinal Oncology
2013;
4
(2)
:173-181
.
(19 June 2013)
Signature of microsatellite instability, KRAS and BRAF gene mutations in German patients with locally advanced rectal adenocarcinoma before and after neoadjuvant 5-FU radiochemotherapy
Journal of Gastrointestinal Oncology
2013;
4
(2)
:182-192
.
(19 June 2013)
Can only chemoradiotherapy and chemotherapy treatment be applied to patients with rectal cancer who could not be operated?
Journal of Gastrointestinal Oncology
2013;
4
(2)
:193-197
.
(19 June 2013)
Treatment outcome of gastric extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in the Hong Kong Chinese population: a single centre experience
Journal of Gastrointestinal Oncology
2013;
4
(2)
:198-202
.
(19 June 2013)
The aspartate aminotransferase to platelet ratio before chemotherapy predicts adverse events for FOLFOX and XELOX regimens including bevacizumab as the first-line therapy for stage IV, recurrent and metastatic colorectal cancer
Journal of Gastrointestinal Oncology
2013;
4
(2)
:203-209
.
(19 June 2013)
Review Articles
Cytopathology of the pancreatobiliary tract–the agony, and sometimes, the ease of it
Journal of Gastrointestinal Oncology
2013;
4
(2)
:210-219
.
(19 June 2013)
Endoscopic ultrasonography for pancreatic cancer: current and future perspectives
Journal of Gastrointestinal Oncology
2013;
4
(2)
:220-230
.
(19 June 2013)
Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib
Journal of Gastrointestinal Oncology
2013;
4
(2)
:231-238
.
(19 June 2013)
Case Report
Small cell carcinoma of the anus in the setting of prior squamous dysplasia and carcinoma in situ
Journal of Gastrointestinal Oncology
2013;
4
(2)
:E1-E4
.
(19 June 2013)
A patient who showed a pathologically complete response after undergoing treatment with XELOX plus bevacizumab for synchronous liver metastasis of grade H2 from sigmoid colon cancer
Journal of Gastrointestinal Oncology
2013;
4
(2)
:E5-E10
.
(19 June 2013)
Solitary gastric metastasis from primary lung adenocarcinoma: a rare site of extra-thoracic metastatic disease
Journal of Gastrointestinal Oncology
2013;
4
(2)
:E11-E15
.
(19 June 2013)
Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC)
Journal of Gastrointestinal Oncology
2013;
4
(2)
:E16-E18
.
(19 June 2013)
